Showing results (1551-1560 of 1,641) with videos related to

Sort By:
Pageof 165
FEBS Letters|June 20, 2012
MicroRNA-23b downregulates peroxiredoxin III in human prostate cancerHui-chan He, Jian-guo Zhu, Xi-bin Chen, et al.
Pediatric Rheumatology Online Journal|October 23, 2023
Potential regulatory role of the Nrf2/HMGB1/TLR4/NF-κB signaling pathway in lupus nephritisShi-Jie Li, Dan-Dan Ruan, Wei-Zhen Wu, et al.
Respiratory Research|August 17, 2023
Echocardiographic evaluation of right heart failure which might be associated with DNA damage response in SU5416-hypoxia induced pulmonary hypertension rat modelMeidan Kuang, Yilin Chen, Yue Xing, et al.
Signal Transduction and Targeted Therapy|April 16, 2026
Reprogramming the tumor microenvironment with antibody against membrane-proximal AXL to overcome immune checkpoint blockade resistanceZuming Yang, Shuaishuai Cao, Jiaen Zhang, et al.
Medical Oncology (Northwood, London, England)|December 17, 2013
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancerYa-Qiang Huang, Zhao-Dong Han, Yu-Xiang Liang, et al.
Plos One|September 3, 2011
Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalingsJian feng Zhu, Zi jian Li, Guang sen Zhang, et al.
Scientific Reports|February 12, 2016
5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomasFeng Zhang, Yifan Liu, Zhiwen Zhang, et al.
Nature Communications|October 1, 2020
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasisLang Rao, Lei Wu, Zhida Liu, et al.
International Journal of Biological Sciences|February 3, 2025
DDX17-Mediated Upregulation of CXCL8 Promotes Hepatocellular Carcinoma Progression <i>via</i> Co-activating β-catenin/NF-κB ComplexHui Liu, Xiaoliang Gao, Wenyao Zhang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 18, 2024
A novel stoploss mutation CYB5R3 c.906A>G(p.*302Trpext*42) involved in the pathogenesis of hereditary methemoglobinemiaKai-Ying He, Hong-Ping Yu, Jing Zou, et al.
Pageof 165